2. DEFINITION:
The ability of a chemical compound to elicit a
pharmacological/ therapeutic effect is related to
the influence of various physical and chemical
(physicochemical) properties of the chemical
substance on the bio molecule that it interacts
with.
1)Physical Properties
Physical property of drug is responsible for its action
2)Chemical Properties
The drug react extracellularly according to simple
chemical reactions like neutralization, chelation, oxidation
etc.
4. ROUTES OF ADMINISTRATION
The choice of appropriate route in a given situation depends
upon both drug as well as patient related factors.
Drugs administered locally or systematically.
The drugs administered through systemic routes is intended to
be absorbed into blood & distributed all over.
5. Different Routes Of Drug Administrations
Oral/ Oral/ Rectal Epithelial Inhalation
Parentral
Swallowed Sublingual
Topical: local effect, substance is applied directly where its action is desired.
Epicutaneous (application onto the skin), e.g. allergy testing, typical local
anesthesia
Inhalational, e.g. asthma medications
Enema, e.g. contrast media for imaging of the bowel
Eye drops (onto the conjunctiva), e.g. antibiotics for conjunctivitis
Ear drops - such as antibiotics and corticosteroids for otitis externa
6. ABSORPTION:
The process by which the drug is released in the body
from its dosage form is known as absorption.
Drug absorption is the movement of a drug into the
bloodstream.
The factors which effect the rate of absorption are
◦ Concentration of the drug
◦ Route of administration
◦ Solubility of the drug
◦ Dissolution rate for solid dosage form
7. ◦ Blood circulation to the site of application and the area of the
absorbing surface in local applications.
◦ Physico-chemical parameters of the drug.
To reach he site of action the drug has to cross one or more
membrane barriers .
The main process by which a drug molecule cross the neutral
barrier is,
◦ Simple diffusion
◦ Facilitated diffusion
◦ Pore transport
◦ Diffusion of the ion across the membrane
◦ Active transport
◦ phagocytosis
7
8. DISTRIBUTION:
Once the drug has been absorbed into the blood ,it
distributed around the body. It get distributed throughout
the blood supply , with in a minute. As the blood
recirculates, the drug moves from the bloodstream into
the body's tissues.
Drug is evenly distributed through out the blood supply,
this does not mean the drug is evenly distributed around
the body . Since he blood supply is rich in some areas of
the body than the other.
8
9. Drugs penetrate different tissues at different speeds,
depending on the drug's ability to cross membranes. For
example, the anesthetic thiopental, a highly fat-soluble drug,
rapidly enters the brain, but the antibiotic penicillin, a water-
soluble drug, does not. In general, fat-soluble drugs can cross
cell membranes more quickly than water-soluble drugs can.
Distribution of a given drug may also vary from person to
person. For instance, obese people may store large amounts
of fat-soluble drugs, whereas very thin people may store
relatively little. Older people, even when thin, may store large
amounts of fat-soluble drugs because the proportion of body
fat increases with aging.
9
10. METABOLISM:
Drug metabolism is the chemical alteration of a drug by
the body.
metabolism is what the body does to the drug,
Some drugs are chemically altered by the body
(metabolized). The substances that result from
metabolism (metabolites) may be inactive, or they may
be similar to or different from the original drug in
therapeutic activity or toxicity. Some drugs, called
prodrugs, are administered in an inactive form, which is
metabolized into an active form.
10
11. The resulting metabolites produce the desired
therapeutic effects. Metabolites may be metabolized
further instead of being excreted from the body. The
subsequent metabolites are then excreted . The
termination of the drug effect is caused by bio
transformation and excretion .all the substance in the
circulatory system , including drugs ,metabolites ,and
nutrients will pass through the liver.
A significant portion of the drug metabolised by hepatic
enzyme to inactive chemical.
11
12. Storage sites
Plasma proteins, certain tissues, neutral fat, bone and
transcelluar fluids(gastro intestinal tract)are found to act
as a drug reservoirs or storage sites for drugs.
Plasma proteins: approximately 6.5% of the blood
constitute the proteins, of which 50% I albumin.
The drug can also be stored in the tissue depots. Neutral
fat constitutes some 20%o 50% of body weight and
constitutes a depot of considerable importance.
12
13. The more lipophilic the drug, the more likely it will concentrate in
these pharmacologically inert depots. The ultra short acting,
lipophilic barbiturate thiopental’s concentration rapidly decreases
below its effective concentration following administration. It
disappears into tissue protein, redistributes into body fat, and then
slowly diffuses back out of the tissue depots but in concentrations
too low for a pharmacological response.
In general, structural changes in the barbiturate series that favours
partitioning into the lipid tissue stores decrease duration of action
but increase central nervous system depression. Conversely, the
barbiturates with the slowest onset of action and longest duration of
action contain the more polar side chains.
13
14. PROTEIN BINDING:
The reversible binding of protein with non-specific and
non- functional site on the body protein with out
showing any biological effect is called as protein
binding.
Protein + drug Protein-drug complex
⇌
Depending on the whether the drug is a weak or
strong acid ,base or is neutral. It can bind to single
blood proteins to multiple proteins. The most
significant protein involved in the binding of drug is
albumin, which comprises more than half of blood
volume.
14
15. protein binding values are normally given as the percentage
of total plasma concentration of drug that is bound to all
plasma protein.
15
Free drug(Df) + Free protein(Pf) Drug /protein complex (Dp)
Total plasma concentration (Dt) = (Df) (Dp
+
16. NEUTRAL FAT:
Since fat constituents around 10%(starvation) to 50% of the total
body weight.it serves as a main storage site for drugs having a high
partition coefficient(lipid/water system) or a high lipid
solubility(thiobarbiturates).
16
17. Drug Receptor Interactions
RECEPTOR
A macromolecular component of the organism that binds
the drug and initiates its effect.
Traditional model was a rigid “Lock and Key”
– Lock Receptor surface
– Key Drug or Ligand
18. TYPES OF RECEPTORS
Four Primary Receptor Families
(i)Ligand-gated ion channels
(ii) G-protein (Guanine nucleotide-regulatory protein) coupled
receptors.
iii) Tyrosine Kinase-linked Receptors
(iv) Intracellular receptors regulating gene transcription
21. Solubility:
• The solubility of a substance at a given temperature is defined
as the concentration of the dissolved solute, which is in
equillibrium with the solid solute.
• Sufficient solubility and membrane permeability is an
important factor for oral absorption.
• The measurement of aqueous solubility depends upon the
following facts.,
1) Buffer & Ionic strength
2) Polymorphism & Purity of the sample
3) pH
4) Super saturation
5) Thermodynamic Vs Kinetic solubility
22. In ascending homologous series, the Physico chemical
properties like boiling point, viscosity, surface activity and
partition coefficient increases then the aqueous solubility
decreases.
The solubility characteristics of a drug can be increased or
decreased by derivatisation.
Eg: Methyl predinisolone acetate(water insoluble) is changed
to Methyl predinisolone Sodium succinate(water soluble).
Eg: Convertion of chloramphenicol(slightly soluble) to
chloramphenicol Palmitate (insoluble)
23. Methods to improve solubility of drugs
1) Structural modification
2) Use of co solvents
3) Employing surfactants
4) Complexation
24. Partition Co-efficient
Partition co-efficient is one of the Physico chemical parameter
which influencing the drug transport & drug distribution., the
way in which the drug reaches the site of action from the site
of application.
Partition co-efficient is defined as equilibrium constant of drug
concentration for a molecule in two phases.
P[Unionized molecule] = [drug]lipid
[drug]water
P[Ionized molecule] = [drug]lipid
[1-a ][drug]water
a=degree of ionization in aqueous solution.
25. Factors affecting Partition Co-efficient
pH
Cosolvents
Surfactant
Complexation
Partition Co-efficient are difficult to measure in living
system.
They are usually determined in vitro 1-octanol as a lipid
phase and phosphate buffer of pH 7.4 as the aqueous
phase.
26. • The Partition co-efficient, P is dimensionless and its
logarithm, log P is widely used as the measure of
lipophilicity.
• The log P is measured by the following methods.
1) Shake flask method
2) Chromatographic method
3) Spectroscopy method
• Phenobarbitone has a high lipid/water partition
coefficient of 5.9. Thiopentone sodium has a
chloroform/water partition coefficient of about
100, so it is highly soluble in lipid.
27. Surface Activity:
surfactant is defined as a material that can reduce the surface
tention of water at low concentration.
Surface active agents affect the drug absorption
which depends on:
1.The chemical nature of surfactant
2.Its concentration
3.Its affect on biological membrane and the miscelle
formation.
28. At lower concentration the surfactant enhances
the absorption rate, the same in higher
concentration reduce the absorption rate.
Applications:
1.The antihelmentic activity of hexylresorcinol
2.Bactericidal activity of cationic quaternary
ammonium compounds.
3.Bactericidal activity of aliphatic alcohols.
4.Disinfectant action of phenol and cresol.
29. Hydrogen Bond
The hydrogen bond is a special dipole-dipole interaction between non
bonding electron pairs of hetero atoms like N, S, O and electron deficient
hydrogen atom in polar bonds such as OH, NH, F etc.
These are weak bonds and denoted as dotted lines.
O-H…….O, HN-H…….O,
• The compounds that are capable, of forming hydrogen
bonding is only soluble in water.
30. Hydrogen bonding is classified in 2 types.
1) Intermolecular hydrogen bonding
R-O-H
H
O R
H-O-R
H
H O H
H O H
O H
H
32. Hydrogen Bonding and biological action
Eg. 1) Antipyrin i.e. 1- phenyl 2,3- dimethyl 5-
pyrazolone has analgesic activity.
N
N
CH3
H3C
O
C6H5
HN
H3C
O
C6H5
HN
H
N
H3C
O
1-phenyl-3-methyl-5-pyrazolone is inactive.
1-phenyl-3-methyl-5-pyrazolone is inactive.
33. C
O
H
O
OH
Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity
Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity
OH C
OH
O
HO C
O
OH
para and meta Hydroxy Benzoic acids are inactive.
para and meta Hydroxy Benzoic acids are inactive.
34. CHELATION
DEFINITON: The compounds that are
obtained by donating electrons to a metal
Ion with the formation of a ring structure are
called chelates.
LIGANDS: The compounds capable of
forming a ring structure with a metal are
termed as ligands.
35. Importance of chelates in medicine:
CH2SH
CHSH
CH2OH
+ As++
CH2S
CHS
CH2OH
As
a)Antidote for metal poisoning
1.Dimercaprol is a chelating agent.
CH3 C
CH3
SH
H
C
NH2
COOH
CU++
CH3 C
CH3
S
H
C
NH2
COOH
CU
CH3 C
CH3
S
H
C
NH2
COOH
UC
NH2 S
HOOC
CH3
CH3
2.Penicillamine
2.Penicillamine
1:1 chelate
1:2 chelate
36. b)8-Hydroxyquinoline and its analogs acts as antibacterial and
anti fungal agent by complexing with iron or copper.
C) Undesirable side effects caused by drugs, which chelates
with metals .
A side effect of Hydralazine a antihypertensive agent is
formation of anemia and this is due to chelation of the drug
with iron.
37. Redox Potential:
The oxidation-reduction potential may be defined as a
quantitative expression of the tendency that a compound has to
give or receive electrons.
The redox potential of a system may be calculated from the
following equation.
E=E0+0.0592/n log[conc. of reductant /conc.of oxidant]
Examples of interfering with natural redox system in
biological conditions:
1) Riboflavin analogues
The biological activity of riboflavin is due to E =-0.185
volt.
38. Examples,
1) Riboflavin analogues
The biological activity of riboflavin is due to E =-
0.185 volt.
N
NH
O
N
OH
OH
OH
OH
N O
riboflavin
Riboflavin E0 = -0.185 V
Riboflavin analogue E0 = -0.095V
N
NH
O
N
OH
OH
OH
OH
N O
Dichloro riboflavin
Cl
Cl
2).The optimum bacteriostatic activity in quinones is associated
with the redox potential at +0.03 volt, when tested against
Staphylococcus aureus.
39. Ionisation and Pka
Most of the drugs are either weak acids or base and can
exist in either ionised or unionised state.
The ionisation of the drug depends on its pKa & pH.
The rate of drug absorption is directly proportional to the
concentration of the drug at absorbable form but not the
concentration of the drug at the absorption site.
Eg: Aspirin in stomach will get readily absorbed because it is in
the un-ionosed form(99%).
Eg; Barbituric acid is inactive because it is strong acid.
5,5 disubstituted Barbituric acid has CNS depressant
action because it is weak acid.
40. Acids are two types-Unionized acid - HA
Ionized acid - BH +
According to Henderson-Hasselbalch equation
PH
= pka
+log[Un ionised form][ionised form
% ionisation = 100( 1+10 (pH-pka)
)
HA H2O H3O+
A-
BH+ H2O H3O+
B
Unionized
Acid
Conjugate
acid
Conugate
base
ionised Conugate
acid
Conugate
base
41. By using drug pKa, the formulation can be adusted to pH to
ensure maximum solubility in water or maximum solubility in
non-polar solvent.
The PH of a substance can be adjusted to maintain
water solubility and complete ionisation.
42. Eg:Phenytoin injection must be adjusted to Ph
12 with Sodium
Hydroxide to obtain 99.98% of the drug in ionised form.
Tropicamide eye drops,an anti cholinergic drug has a pka of
5.2 and the drug has to be buffered to Ph
4 to obtain more than
90% ionisation.
43. OH
O
H
OH
O
H
trans-diethylstibesterol
Estrogenic activity
cis-diethylstibesterol
Only 7% activity
of the trans isomer
The drug most possess a high degree of structural specificity or stereo
selectivity.
Many drugs show stereo selectivity because mostly reeptor binds are optically
active biological macromolecules such as protein, polynuclootide or glycolipds.
For e.g. Diethyl stilbosterol
44. Conformational Isomers
Different arrangement of atoms that can be converted into
one another by rotation about single bonds are called
conformations.
Rotation about bonds allows inter conversion of conformers.
45. A classical example is of acetylcholine which can exist in different
conformations.
Staggered
2-Acetoxycyclo propyl trimethyl ammonium iodide
H H
N+
H
H
OCOCH3
H
H
N+
H
H
OCOCH3
Eclipsed
H3COCO H
N
H
H
H
GAUCHE
H
OCOCH3
N
H
H
H
Fully Eclipsed
N+
O
O
I-
46. Optical Isomers
Stereochemistry, enantiomers, symmetry and chirality
are impotant concept in therapeutic and toxic effect
of drug.
A chiral compound containing one asymmetric centre
has two enantiomers. Although each enantiomer has
identical chemical & physical properties, they may have
different physiological activity like interaction with
receptor, metabolism & protein binding.
A optical isomers in biological action is due to one
isomer being able to achieve a three point attachment
with its receptor molecule while its enantiomer would
only be able to achieve a two point attachment with
the same molecule.
48. E.g. Ephedrine & Psuedoephedrine
MP = 37-39
1 gram/20 mL
MP = 118-120
1 gram/200 mL
Ephedrine
(Erythro)
CH3
OH
H
NHCH3
H
Pseudoephedrine
(Threo)
CH3
H
O
H
NHCH3
H
49. The category of drugs where the two isomers have
qualitatively similar pharmacological activity but have
different quantitative potencies.
O
O
OH
O
(s)-(-)warfarin
O
O
OH
O
(R)-(+)warfarin
50. Geometric Isomerism
Geometric isomerism is represented by cis/trans
isomerism resulting from restricted rotation due to
carbon carbon double bond or in rigid ring system.
OH
O
H
OH
O
H
trans-diethylstibesterol
Estrogenic activity
cis-diethylstibesterol
Only 7% activity
of the trans isomer
51. Longmuir introduced the term isosterism in 1919, which
postulated that two molecules or molecular fragments
containing an identical number and arrangament of electron
should have similar properties and termed as isosteres.
Isosteres should be isoelectric i.e. they should possess same
total charge.
52. Bioisosterism is defined as compounds or groups that possess
near or equal molecular shapes and volumes, approximately
the same distribution of electron and which exhibit similar
physical properties.
They are classified into two types.,
i)Classical biososteres
ii)Non classical bioisosters.
53. Classical Bioisosteres
They have similarities of shape and electronic configuration of
atoms, groups and molecules which they replace.
The classical bioisosteres may be,
Univalent atoms and groups
i)cl, Br, I ii) CH3NH2, -OH, -SH
Bivalent atoms and groups
i) R-OR,RNH-R, RSR,RSeR
ii) –CONHR, -COOR, -COSR
54. Trivalent atoms and groups
i)-CH=, -N= ii) –p=, -AS=
Tetravalent atoms and groups
=c=, =N=, =P=
55. Application of Classical Bioisosteres in in drug design
i) Replacement of –NH 2 group by –CH3 group.
Carbutamide R= NH2
Tolbutamide R= CH3
ii)Replacement of –OH & -SH
Guanine= -OH
6-Thioguanine = -SH
R SO2 NH CONH(CH2)3CH3
NH
N
N
H2N
HN
X
56. Non classical Bioisosteres
They do not obey the stearic and electronic
definition of classical isosteres.
These isosteres retain activity by the retention of
their properties such as pKa, electrostatic
potentials, which can alter selective enzyme
processes.
57. Examples
Halogens cl, F, Br,CN
Ether -S-, -O-
Carbonyl group
Hydroxyl group –OH, -NHSO2R, CH2OH
Catechol
HO
HO
Catechol
O
S
O O
N
H
N
58. A classical e.g. of ring Vs. noncycclic structure is
Diethylstilbosterol & 17-ß oestradiol.
17-ß oestradiol.
HO
OH
H
H
H
OH
HO
trans-diethylstibesterol
59. REFERENCES:
1.Thomas L . LEMKE , David A . WILLIAMS , Victoria
F.ROCHE,S . William ZITO, Foye’s Principles of
Medicinal Chemistry ,Wolters kluwer Pvt .Ltd, New
Delhi , 6th
Edition ,Pg . no. 210 – 298.
2.William A.Remers,Jaimes N .Delgado, Wilson&
Grissvold’s Text book of organic, Medicinal and
pharmaceutical Chemistry ,10th
Edition ,Pg .no.3-10
59
60. 3. DonaldJ. Abraham ,BURGER’S Medicinal chemistry Drug
Discovery , Wiley inter science publication ,
6th
Edition ,Volume -2, Pg. no. 649 – 653.
4. Rama rao Nadendla ,Principles of organic Medicinal Chemistry ,
New age International Pvt . Limited Publishers , Pg . no. 14 - 28.
5. www.wikipedia.com
60